Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Vera Therapeutics, Inc. (VERA) had Free Cash Flow per Share of $-0.86 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-51.69M |
|
-- |
|
-- |
|
$57.19M |
|
$-57.19M |
|
$5.50M |
|
$-51.69M |
|
$-51.69M |
|
$-51.69M |
|
$-51.69M |
|
$-51.69M |
|
$-51.69M |
|
$-57.19M |
|
$-59.42M |
|
63.67M |
|
63.67M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$606.08M |
|
$1.06M |
|
$4.09M |
|
$610.17M |
|
$21.89M |
|
$50.91M |
|
$53.27M |
|
$75.17M |
|
$535.00M |
|
$535.00M |
|
$535.00M |
|
63.77M |
|
| Cash Flow Statement Financials | |
$-54.41M |
|
$15.32M |
|
$1.53M |
|
$92.65M |
|
$55.09M |
|
$-37.56M |
|
$7.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.68 |
|
-- |
|
-- |
|
0.09 |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-54.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.66% |
|
-9.66% |
|
-8.47% |
|
-8.82% |
|
$8.39 |
|
|
Free Cash Flow per Share |
$-0.86 |
$-0.85 |
|